DS
Debomita Sengupta
Chittaranjan National Cancer Institute, Bose Institute - Centenary Campus, Institute of Life Sciences, University of Calcutta, Bidhannagar College
0000-0001-8359-1763
Employment
-
Chittaranjan National Cancer Institute CSIR-Senior Research Associate (Scientists' Pool)2021 - Present
-
Bose Institute - Centenary Campus National Postdoctoral Fellow (DST-SERB)2017 - 2019
-
Institute of Life Sciences Ph.D student2008 - 2015
Education
-
Institute of Life Sciences PhD (Life Sciences)2007 - 2015
-
University of Calcutta M.Sc2005 - 2007
-
Bidhannagar College B.Sc2002 - 2005
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- A peripheral blood-based approach involving vimentin along with AURKA enabled efficient tracking of elusive Oct4/Sox2-expressing disseminated breast cancer stem cells Save
- Aurora Kinase A inhibitor alisertib failed to exert its efficacy on TNBC cells due to consequential enrichment of polyploid giant cancer cells (PGCCs) Save
- Oct4/Sox2 positive breast cancer stem cell-like cells can be detected and targeted by including AURKA and Vimentin in the combinatorial marker profile Save
- Neutrophils in Cancer and Potential Therapeutic Strategies Using Neutrophil-Derived Exosomes Save
- Neutrophils in Cancer and Potential Therapeutic Strategies using Neutrophil-derived Exosomes Save
- Aspirin Restores Radiosensitivity in Cervical Cancer Cells by Inducing Mitotic Catastrophe through Downregulating G2/M Effectors Save
- Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer Save
- AURKA/NFκB Axis: A Key Determinant of Radioresistance in Cervical Squamous Carcinoma Cells Save
- Insights of Cisplatin Resistance in Cervical Cancer: A Decision Making for Cellular Survival Save
- SMAR1 repression by pluripotency factors and consequent chemoresistance in breast cancer stem-like cells is reversed by aspirin Save